By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Orexigen Therapeutics, Inc. 

48 Wall Street
Suite 1100
New York  New York  10005  U.S.A.
Phone: 212-918-4650 Fax: 212-918-4801


SEARCH JOBS


Industry
Biotechnology






Company News
Orexigen (OREX) Announces Second Quarter 2017 Financial Results 8/9/2017 12:17:16 PM
Orexigen (OREX) Announces Commercialization And Distributorship Arrangement With Cheplapharm Arzneimittel GmbH For Mysimba In Germany, France And Austria 8/7/2017 7:52:33 AM
Orexigen (OREX) To Provide Business Update And Discuss Second Quarter 2017 Financial Results On August 8, 2017 7/26/2017 8:40:40 AM
Orexigen (OREX) Announces Expansion Of Distributorship Agreement With Biologix FZCO For Contrave (Naltrexone Hcl / Bupropion Hcl Extended Release) To Egypt 7/26/2017 7:39:54 AM
VIVUS (VVUS) Settlement Could Clue In Orexigen (OREX) Investors 7/21/2017 6:35:10 AM
Orexigen (OREX) Reports Financial Results For The First Quarter Ended March 31, 2017 5/10/2017 10:40:58 AM
Orexigen (OREX) Announces Commercialization And Distributorship Arrangement With Navamedic ASA For Mysimba (Naltrexone Hcl / Bupropion Hcl Prolonged Release) In Five Nordic Countries 5/2/2017 6:38:07 AM
Orexigen (OREX) To Provide Business Update And Discuss First Quarter 2017 Financial Results On May 9, 2017 4/26/2017 10:35:31 AM
Orexigen (OREX) Announces New Drug Submission For Contrave In Canada 4/25/2017 7:55:30 AM
Orexigen (OREX) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2016 3/29/2017 8:38:55 AM
12345678910...
//-->